Drug Profile
UK 464273
Alternative Names: UK 464,273Latest Information Update: 10 Aug 2009
Price :
$50
*
At a glance
- Originator Pfizer
- Class Erectile dysfunction therapies
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Premature ejaculation
Most Recent Events
- 10 Aug 2009 Discontinued - Phase-II for Premature ejaculation in USA (unspecified route)
- 07 Jan 2005 Phase-II clinical trials in Premature ejaculation in USA (unspecified route)